| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $149.7M | +29.9% |
| Cost of Revenue | $27.4M | +24.0% |
| R&D Expense | $43.6M | +73.8% |
| SG&A Expense | $44.2M | -54.9% |
| Operating Income | -$38.0M | +43.5% |
| Pre-tax Income | -$23.2M | +65.7% |
| Income Tax | $2.3M | -15.9% |
| Net Income | -$25.6M | +63.8% |
| EPS (Basic) | -$0.71 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $184.4M | -27.6% |
| Accounts Receivable | $56.0M | -34.2% |
| Current Assets | $278.0M | -26.7% |
| Total Assets | $424.8M | -15.8% |
| Current Liabilities | $193.3M | +1.1% |
| Total Liabilities | $344.9M | -18.7% |
| Stockholders' Equity | $79.9M | -0.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.7M | -48.3% |
| Capital Expenditures | $4.8M | +369.0% |
| Investing Cash Flow | -$12.1M | +77.5% |
| Financing Cash Flow | -$61.9M | -133.2% |
| Free Cash Flow | -$1.0M | -116.5% |
| +63.4% |
| EPS (Diluted) | -$0.71 | +64.0% |